This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) To 2017: Global Analysis

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market & Forecast – (2010 – 2017)

3. Molecular Diagnostics Market Share – (2010 – 2017) 3.1 Molecular Diagnostics Market Share & Forecast – Application Wise3.2 Molecular Diagnostics Market Share & Forecast – Technology Wise3.3 Molecular Diagnostics Market Share & Forecast – Region Wise3.4 Molecular Diagnostics Market Share & Forecast – Company Wise

4. Molecular Diagnostics Market (Application Segment) – (2010 – 2017) 4.1 Infectious Disease Testing Market & Forecast4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast4.1.2 Health – Associated Infections (HAI) Testing Market & Forecast4.1.3 HPV Testing Market & Forecast4.1.4 Critical Care Infectious Testing Market & Forecast4.2 Blood Screening Market & Forecast4.3 Genetic Testing Market & Forecast4.4 Oncology Testing Market & Forecast4.5 Tissue Typing (HLA Testing) Market & Forecast4.6 Cardiovascular Disease Testing Market & Forecast4.7 Neurological Disorders Testing Market & Forecast4.8 Food Pathogen Detection Testing Market & Forecast4.9 Miscellaneous Testing Market & Forecast

5. Molecular Diagnostics Market (Technologies Segment) – (2010 – 2017) 5.1 PCR Based Test Market & Forecast5.2 PCR Related Technologies Market & Forecast5.3 Non-PCR Test Market & Forecast5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast5.5 Biochips/Microarrays Market & Forecast5.6 Biosensors Market & Forecast5.7 Molecular Imaging Market & Forecast5.8 Other Technologies Market & Forecast

6. Geographical Distribution – Molecular Diagnostics Market – (2008 – 2017) 6.1 United States Molecular Diagnostics Market & Forecast6.2 Europe Molecular Diagnostics Market & Forecast6.3 China Molecular Diagnostics Market & Forecast6.4 Japan Molecular Diagnostics Market & Forecast6.5 India Molecular Diagnostics Market & Forecast6.6 Brazil Molecular Diagnostics Market & Forecast6.7 Mexico Molecular Diagnostics Market & Forecast6.8 South Korea Molecular Diagnostics Market & Forecast6.9 Rest of World Molecular Diagnostics Market & Forecast

7. Molecular Diagnostics Market (Company Wise) – (2010 – 2017) 7.1 Roche Molecular Diagnostics Market & Forecast7.2 Abbott Molecular Diagnostics Market & Forecast7.3 Myriad Genetics Molecular Diagnostics Market & Forecast7.4 Qiagen Molecular Diagnostics Market & Forecast7.5 BioMérieux Molecular Diagnostics Market & Forecast7.6 Other Companies Molecular Diagnostics Market & Forecast

8. Molecular Diagnostics and Personalized Medicine8.1 Road to Personalized Medicine8.1.1 Historical perspective: HIV & Oncology8.1.2 Other Applications: Met & Unmet Therapy Areas

8.2 Molecular Diagnostics Technologies8.2.1 Expression Profiling - RNA & Pharmacogenomics8.2.2 Expression Profiling - Proteins & Pharmacoproteomics8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis8.2.4 DNA Sequence Profiling - High-Throughput Sequencing

3 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,856.78 -278.94 -1.54%
S&P 500 2,071.26 -29.78 -1.42%
NASDAQ 4,927.37 -55.4390 -1.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs